SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
31-Jul-24 6:05 PM View: | Fate Therapeutics Inc (FATE) | 29-Jul-24 | Grant | 200,000 | -- | -- | 127% 158.07K to 358.07K | |
10-Jan-24 4:30 PM View: | Fate Therapeutics Inc (FATE) | 09-Jan-24 | Sale | 11,271 | $4.38 | $49,367.00 | (7%) 169.34K to 158.07K | |
13-Jan-23 4:02 PM View: | Fate Therapeutics Inc (FATE) | 12-Jan-23 | Option Exercise | 423 | $1.37 | $579.51 | < 1% 168.92K to 169.34K | |
11-Jan-23 4:08 PM View: | Fate Therapeutics Inc (FATE) | 10-Jan-23 | Sale | 10,917 | $5.24 | $57,205.10 | (6%) 179.83K to 168.92K | |
08-Jul-22 4:51 PM View: | Fate Therapeutics Inc (FATE) | 07-Jul-22 | Option Exercise | 17,158 | $2.73 | $46,841.30 | 10% 179.83K to 196.99K | |
08-Jul-22 4:51 PM View: | Fate Therapeutics Inc (FATE) | 07-Jul-22 | Planned Option Sale | 17,158 | $30.23 | $518,686.00 | (9%) 196.99K to 179.83K | |
07-Jul-22 4:04 PM View: | Fate Therapeutics Inc (FATE) | 06-Jul-22 | Option Exercise | 7,842 | $3.27 | $25,628.70 | 4% 179.83K to 187.68K | |
07-Jul-22 4:04 PM View: | Fate Therapeutics Inc (FATE) | 06-Jul-22 | Planned Option Sale | 7,842 | $30.07 | $235,809.00 | (4%) 187.68K to 179.83K | |
15-Mar-22 4:27 PM View: | Fate Therapeutics Inc (FATE) | 14-Mar-22 | Option Exercise | 25,000 | $2.73 | $68,250.00 | 14% 179.83K to 204.83K | |
15-Mar-22 4:27 PM View: | Fate Therapeutics Inc (FATE) | 14-Mar-22 | Planned Option Sale | 25,000 | $31.07 | $776,733.00 | (12%) 204.83K to 179.83K | |
27-Jan-22 4:38 PM View: | Fate Therapeutics Inc (FATE) | 25-Jan-22 | Grant | 33,302 | -- | -- | 23% 146.53K to 179.83K | |
13-Jan-22 4:07 PM View: | Fate Therapeutics Inc (FATE) | 11-Jan-22 | Market Sale | 4,570 | $48.50 | $221,655.00 | (3%) 151.1K to 146.53K | (2%) |
12-Jan-22 4:05 PM View: | Fate Therapeutics Inc (FATE) | 10-Jan-22 | Market Sale | 5,596 | $46.38 | $259,558.00 | (4%) 156.7K to 151.1K | (6%) |
14-Dec-21 4:18 PM View: | Fate Therapeutics Inc (FATE) | 13-Dec-21 | Option Exercise | 25,000 | $2.73 | $68,250.00 | 16% 156.7K to 181.7K | |
14-Dec-21 4:18 PM View: | Fate Therapeutics Inc (FATE) | 13-Dec-21 | Market Option Sale (Planned) | 25,000 | $47.66 | $1,191,410.00 | (14%) 181.7K to 156.7K | |
22-Nov-21 5:44 PM View: | Fate Therapeutics Inc (FATE) | 19-Nov-21 | Grant | 60,958 | -- | -- | 64% 95.74K to 156.7K | |
14-Sep-21 4:01 PM View: | Fate Therapeutics Inc (FATE) | 13-Sep-21 | Option Exercise | 25,000 | $2.73 | $68,250.00 | 26% 95.74K to 120.74K | |
14-Sep-21 4:01 PM View: | Fate Therapeutics Inc (FATE) | 13-Sep-21 | Market Option Sale (Planned) | 25,000 | $66.29 | $1,657,260.00 | (21%) 120.74K to 95.74K | |
16-Jun-21 4:26 PM View: | Fate Therapeutics Inc (FATE) | 14-Jun-21 | Option Exercise | 25,000 | $2.84 | $70,996.50 | 26% 95.74K to 120.74K | |
16-Jun-21 4:26 PM View: | Fate Therapeutics Inc (FATE) | 14-Jun-21 | Market Option Sale (Planned) | 25,000 | $89.32 | $2,233,050.00 | (21%) 120.74K to 95.74K | |
16-Mar-21 4:05 PM View: | Fate Therapeutics Inc (FATE) | 15-Mar-21 | Option Exercise | 25,000 | $2.90 | $72,500.00 | (17%) 145.74K to 120.74K | |
16-Mar-21 4:05 PM View: | Fate Therapeutics Inc (FATE) | 15-Mar-21 | Market Sale (Planned) | 25,000 | $92.35 | $2,308,770.00 | (21%) 120.74K to 95.74K | |
22-Jan-21 6:22 PM View: | Fate Therapeutics Inc (FATE) | 20-Jan-21 | Grant | 18,013 | -- | -- | 23% 77.73K to 95.74K | |
12-Jan-21 8:40 PM View: | Fate Therapeutics Inc (FATE) | 11-Jan-21 | Market Sale | 3,254 | $110.81 | $360,588.00 | (4%) 80.98K to 77.73K | (1%) |
12-Jan-21 8:40 PM View: | Fate Therapeutics Inc (FATE) | 08-Jan-21 | Market Sale | 6,230 | $117.10 | $729,552.00 | (7%) 87.21K to 80.98K | 4% |
15-Dec-20 4:01 PM View: | Fate Therapeutics Inc (FATE) | 14-Dec-20 | Option Exercise | 25,000 | $2.90 | $72,500.00 | 29% 87.21K to 112.21K | |
15-Dec-20 4:01 PM View: | Fate Therapeutics Inc (FATE) | 14-Dec-20 | Market Option Sale (Planned) | 25,000 | $97.78 | $2,444,480.00 | (22%) 112.21K to 87.21K | (3%) |
16-Sep-20 4:02 PM View: | Fate Therapeutics Inc (FATE) | 14-Sep-20 | Option Exercise | 25,000 | $2.75 | $68,778.00 | 29% 87.21K to 112.21K | |
16-Sep-20 4:02 PM View: | Fate Therapeutics Inc (FATE) | 14-Sep-20 | Market Option Sale (Planned) | 25,000 | $36.28 | $907,024.00 | (22%) 112.21K to 87.21K | (178%) |
04-Feb-20 4:01 PM View: | Fate Therapeutics Inc (FATE) | 03-Feb-20 | Option Exercise | 1,153 | $1.69 | $1,948.57 | 1% 86.06K to 87.21K | |
10-Jan-20 4:03 PM View: | Fate Therapeutics Inc (FATE) | 08-Jan-20 | Grant | 25,000 | -- | -- | 37% 66.76K to 91.76K | |
10-Jan-20 4:03 PM View: | Fate Therapeutics Inc (FATE) | 08-Jan-20 | Market Sale | 5,700 | $20.69 | $117,947.00 | (6%) 91.76K to 86.06K | (387%) |
16-Oct-19 4:06 PM View: | Fate Therapeutics Inc (FATE) | 15-Oct-19 | Market Sale | 6,200 | $14.18 | $87,890.60 | (8%) 72.96K to 66.76K | (610%) |
09-Jan-19 4:04 PM View: | Fate Therapeutics Inc (FATE) | 07-Jan-19 | Grant | 45,000 | -- | -- | 161% 27.96K to 72.96K |